RSS-Feed abonnieren
DOI: 10.1160/TH08-11-0747
Do common prothrombotic mutations influence the risk of cerebral ischaemia in patients with patent foramen ovale?
Systematic review and meta-analysisPublikationsverlauf
Received:
14. November 2008
Accepted after minor revision:
11. Januar 2009
Publikationsdatum:
24. November 2017 (online)
Summary
Conflicting results are available on the association of prothrombotic genetic abnormalities with patent foramen ovale (PFO)-related cerebral ischaemia. We comprehensively sought and identified studies of the association of both the factor V Leiden (FVG1691A mutation) and the prothrombin mutation (PTG20210A mutation) with PFO-related cerebral ischaemia and did meta-analyses to assess the evidence for such a relation. We analysed data from six eligible studies in 856 cases and 1,001 control subjects. Additional unpublished data from a new series including 463 subjects were also entered into the analysis. The PTG20210A variant was significantly associated with PFO-related stroke in comparison with both control subjects (odds ratio [OR] 3.85; 95% confidence interval [CI] 2.22 to 6.66) and non-PFO-associ ated stroke patients (OR 2.31; 95% CI 1.20 to 4.43), whereas a trend toward an association was observed for the FVG1691A mutation (OR 1.18; 95% CI 0.73 to 1.90, compared to control subjects; OR 1.14; 95% CI 0.62 to 2.09, compared to non-PFO-associated stroke patients). The status of carrier of either the FVG1691A mutation or the PTG20210A variant was associated with a risk for stroke of 1.98 (95% CI 1.38 to 2.83) and 1.62 (95% CI 1.03 to 2.57), as compared to control subjects and non-PFO-associated stroke patients, respectively. Addition of common prothrombotic genetic variants to standard initial screening may contribute to stratifying PFO-associated stroke patients at different risk of ischaemic events and targeting secondary prevention strategies.
-
References
- 1 Thaler DA, Saver JL. Cryptogenic stroke and patent foramen ovale. Curr Opin Cardiol 2008; 23: 537-544.
- 2 Saver JL. Cryptogenic stroke in patients with patent foramen ovale. Curr Atheroscler Rep 2007; 09: 319-325.
- 3 Pezzini A, Del Zotto E, Magoni M. et al. Inherited thrombophilic disorders in young adults with ischaemic stroke and patent foramen ovale. Stroke 2003; 34: 28-33.
- 4 Lichy C, Reuner KH, Buggle F. et al. Prothrombin G20210A mutation, but not factor V Leiden, is a risk factor in patients with persistent foramen ovale and otherwise unexplained cerebral ischaemia. Cerebrovasc Dis 2003; 16: 83-87.
- 5 Belvis R, Santamaria A, Marti-Fabregas J. et al. Patent foramen ovale and prothrombotic markers in young stroke patients. Blood Coagul Fibrinolysis 2007; 18: 537-542.
- 6 Offelli P, Zanchetta M, Pedon L. et al. Thrombophilia in young patients with cryptogenic stroke and patent foramen ovale (PFO). Thromb Haemost 2007; 98: 906-907.
- 7 Karttunen V, Hiltunen L, Rasi V. et al. Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent for-amen ovale. Blood Coagul Fibrinolysis 2003; 14: 261-268.
- 8 Botto N, Spadoni I, Giusti S. et al. Prothrombotic mutations as risk factors for cryptogenic ischaemic cerebrovascular events in young subjects with patent for-amen ovale. Stroke 2007; 38: 2070-2073.
- 9 Silver MD, Dorsey GS. Aneurysms of the septum primum in adults. Arch Pathol Lab Med 1978; 102: 62-65.
- 10 Schneider B, Hanrath P, Vogel P. et al. Improved morphologic characterization of atrial septal aneurysm by transesophageal echocardiography: relation to cerebrovascular events. J Am Coll Cardiol 1990; 16: 1000-1009.
- 11 Berthet K, Lavergne T, Cohen A. et al. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischaemic stroke of unknown cause. Stroke 2000; 31: 398-403.
- 12 Martinelli I, Battaglioli T, Razzari C. et al. Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia. J Thromb Haemost 2007; 05: 98-101.
- 13 Egger M, Davey Smith G. Meta-analysis. Bias in location and selection of studies. Br Med J 1998; 316: 61-66.